Edwards Life Sciences Corp. (EW): Today's Featured Health Services Laggard

Edwards Life ( EW) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.7%. By the end of trading, Edwards Life fell 90 cents (-0.9%) to $100.42 on light volume. Throughout the day, 759,849 shares of Edwards Life exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $99.76-$101.61 after having opened the day at $100.75 as compared to the previous trading day's close of $101.32. Other company's within the Health Services industry that declined today were: Assisted Living Concepts ( ALC), down 16.3%, Neostem ( NBS), down 8.8%, Navidea Biopharmaceuticals ( NAVB), down 7.5%, and Graymark Healthcare ( GRMH), down 7.3%.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. Edwards Life has a market cap of $11.38 billion and is part of the health care sector. The company has a P/E ratio of 45.1, below the average health services industry P/E ratio of 47.7 and above the S&P 500 P/E ratio of 17.7. Shares are up 41.5% year to date as of the close of trading on Friday. Currently there are nine analysts that rate Edwards Life a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front, NeuroMetrix ( NUROD), up 23.1%, Dehaier Medical Systems ( DHRM), up 20.5%, Retractable Technologies ( RVP), up 14.3%, and Gentiva Health Services ( GTIV), up 12.1%, were all gainers within the health services industry with Zimmer Holdings ( ZMH) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock